ANVS
Annovis Bio Inc
NYSE: ANVS · HEALTHCARE · BIOTECHNOLOGY
$1.98
+7.34% today
Updated 2026-04-30
Market cap
$60.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.40
Dividend yield
—
52W range
$1 – $6
Volume
0.8M
Annovis Bio Inc (ANVS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2009 | 2010 | 2011 | 2012 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-389230.00 | $-1.77M | $-3.01M | $-1.41M | $-537481.00 | $-558609.00 | $-476542.00 | $-3.97M | $-9.13M | $-17.31M | $-39.97M | $-21.89B | $-25.62B |
| Capital expenditures | $5160.00 | $155870.00 | $79604.00 | $79604.00 | $0.00 | $0.00 | $0.00 | $3.00 | $0.00 | $4.00 | $4.00 | $4.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | $48495.00 | $82728.00 | $8483.00 | $1.86M | $4.70M | $9.15M | $4.63M | $3.84B | $1.80B |
| Free cash flow | $-394390.00 | $-1.93M | $-3.09M | $-1.49M | $-537481.00 | $-558609.00 | $-476542.00 | $-3.97M | $-9.13M | $-17.31M | $-39.97M | $-21.89B | $-25.62B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | $8.07M | $37.61M | — | — | — | — |